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Abstract 
Studies indicate that hyperthermic therapy using gold nanorods and photodynamic 
activity with many photosensitizers can present a synergistic effect, and offer a great 
therapeutic potential, although more investigation needs to be performed before such 
approach could be implemented. We proposed to investigate the effect of the attachment 
of phthalocyanines on the surface of gold nanorods (well-characterized devices for 
hyperthermia generation) for the elimination of melanoma, one of the most important 
skin cancers due to its high lethality. Following the synthesis of nanorods through a 
seed-mediated method, the efficacy of photodynamic therapy (PDT) and hyperthermia 
was assessed separately. We chose to coat the nanorods with two tetracarboxylated zinc 
phthalocyanines - with or without methyl-glucamine groups. After the coating process, 
the phthalocyanines formed ionic complexes with the cetyltrimethylammonium bromide 
(CTAB) that was previously covering the nanoparticles. The nanorod-phthalocyanines 
complexes were analyzed by transmission electron microscopy (TEM), and their singlet 
oxygen and hydroxyl radical generation yields were assessed. Furthermore, they were 
tested in vitro with melanotic B16F10 and amelanotic B16G4F melanoma cells. The 
cells with nanoparticles were irradiated with laser (at 635 nm), and the cell viability was 
assessed. The results indicate that the photodynamic properties of the phthalocyanines 
tested are enhanced when they are attached on the nanorods surface, and the 
combination of PDT and hyperthermia was able to eliminate over 90% of melanoma 
cells. This is a novel study because two tetracarboxylated phthalocyanines were used 
and because the same wavelength was irradiated to activate both the nanorods and the 
photosensitizers. 
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1. INTRODUCTION 
 
 
 Malignant melanoma is one of the most lethal types of cancer, and its incidence has 
been growing lately: according to World Health Organization, around 132,000 new melanoma 
cases are diagnosed every year. Although melanoma represents the minority of skin cancer 
cases,  it is the main responsible for cancer mortality. 
 Classic treatments for cancer include the surgical removal of solid tumors, radiotherapy, 
chemotherapy, immunotherapy, hormone-therapy, and others. However, due to the high 
regrowth rates, as well as to the organic impairment caused by those interventions, there has 
been an increasing search for new and more efficient therapeutic interventions, especially less 
invasive ones (1). Over the last decades, an effort has been made towards the development of 
light-based therapies, most of them based on the effects of light interaction with tissues (2) such 
as hyperthermia. Studies indicate that temperatures between 42º and 47º C can induce cell 
death, proportionally to the time of irradiation, either by necrosis or by apoptosis (3). Apoptosis 
can be activated after hyperthermia due to the increased expression of p53 protein, or due to 
membrane blebbing (4). 
 The hyperthermic effect can be achieved directly by the interaction of light with the 
tissues, but can also be enhanced if some devices are used, i.e. plasmonic nanoparticles. One of 
the most common type of nanoparticles used in the last decades is colloidal gold, usually 
covered with a polymer like polyethylene glycol (PEG). Those nanoparticles can consist of pure 
gold or they can have a silica core in case of nanoshells (5). Gold nanoparticles are promising 
because of their low toxicity, conformational flexibility and intense plasmonic surface 
resonance with visible light and near infrared light (6). This last property allows the generation 
of heat via the interaction with light (7,8). 
 Another effect caused by light in biological systems is the photodynamic effect, as long 
as a photosensitizer compound is present on the target tissue. Photosensitizers are able to induce 
phototoxic effects, i.e. reactive oxygen species (ROS) and singlet oxygen generation, after their 
activation by light in a specific wavelength and when molecular oxygen is present. Basically, 
light takes the photosensitizer molecule up to a short-lived, excited, singlet state. Then, if the 
photosensitizer undergoes an intersystem transition, in which the excited singlet state becomes a 
triplet state, it can exchange energy with molecular oxygen, whose ground state is a triplet one.  
This triplet-triplet annihilation restores the ground singlet state to the photosensitizer and turns 
triplet oxygen into singlet oxygen. Singlet oxygen can, in turn, react with many biological 
molecules in a very localized manner, therefore photodynamic therapy (PDT) consists of a safe 
and efficient treatment for cancer (9,10). 
 
 Since hyperthermia and the photodynamic effect can be achieved with light, both 
therapeutic interventions could be combined in order to diminish the concentration of 
photosensitizers and nanoparticles required for the treatment. Some lines of evidence show that 
hyperthermia and photodynamic therapy can act synergistically, with deeper damage being 
caused specifically to malignant tissues  and, consequently, higher success rates being achieved 
(11). If hyperthermia is applied right after PDT, the synergistic effect is optimized, but if there 
is an interval between the procedures, this synergism tends to disappear. Besides, if PDT is 
applied after hyperthermia, the efficacy is lost, since the higher temperatures can turn the tissue 
darker due to hemorrhage, and this would prevent further light penetration and diminish oxygen 
supply for the photosensitizer (12). 
 The synergy between both therapeutic interventions can be explained, for instance, by 
the fact that individual therapies are insufficient to induce a thorough malignant tissue death, but 
if they are applied together, the extent of cell death is augmented. Besides, the thermal energy 
generated by the irradiated nanoparticles is able to accelerate the generation of reactive oxygen 
species and singlet oxygen (13). These features are important for the treatment of melanotic 
melanomas, since melanin tends to absorb the light required for the photodynamic effect, 
decreasing the effectiveness of PDT. Only a more potent therapeutic intervention could 
overcome the resistance of melanomas against photonic therapies.  
 In this study, we proposed to investigate the synergistic effect and the efficacy of both 
photodynamic and hyperthermic effect using gold nanorods in vitro against melanomas, as well 
as the likelihood of synthesizing gold nanorods covered with phthalocyanines. 
 
 
2. METHODS 
 
2.1. Nanorods synthesis 
 A seed-mediated method was used. Basically, 5 mL of cetyltrimethylammonium 
bromide (CTAB) (0.2 mol L-1) were mixed with 5 mL of chloroauric acid (HAuCl4) (5x10-4 mol 
L-1). After stirring, 600 μL of sodium borohydride (1x10-2 mol L-1) were added. The solution 
was vigorously stirred for 2 minutes, and then it was left standing for 6 hours in the dark. This 
procedure led to the formation of small nanospheres called seeds. On a second step, 200 μL of 
silver nitrate (0.004 mol L-1) were added to 5 mL of CTAB (0.2 mol L-1) and 5 mL of HAuCl4 
(0.001 mol L-1). Then, 70 μL of ascorbic acid (0,0788 mol L-1) were added to the yellow 
solution while stirring, turning the solution colorless. Finally, 12 μL of the seeds suspension 
were added to this solution, and the mixture was left standing for 15 minutes, the time when the 
color of colloidal gold is able to be seen (14). 
  
 
2.3. Nanorods coating with phthalocyanines 
 Two zinc phthalocyanines were used: a tetracarboxylated zinc phthalocyanine (ZnTcPc) 
and a methylglucaminated tetracarboxylated zinc phthalocyanine (ZnTcPc-G). They were 
chosen because of their negative charge and their efficiency in PDT. 10 µmol L-1 of each 
photosensitizer were added separately to 5 mL of the nanorods suspension, and both mixtures 
were left under stirring overnight. The positively-charged CTAB from the nanorods forms an 
ionic complex with the negatively-charged phthalocyanine. The extinction coefficients of 
CTAB-coated nanorods and phthalocyanine-coated nanorods were used to calculate the amount 
of photosensitizer complexed with the nanorods (15). As a further characterization, the 
morphology of the nanoparticles was assessed by transmission electron microscopy (TEM), 
with magnifications of 18,000X and 46,000X. 
 
2.4. Singlet Oxygen and Reactive Oxygen Species (ROS) generation assessment 
 The generation of singlet oxygen and hydroxyl radicals was assessed using a 
commercial kit. For singlet oxygen, the probe Singlet Oxygen Sensor Green was added to the 
nanorods suspensions in a final concentration of 5 µmol L-1 (with and without photosensitizer 
in a concentration of 4 µmol L-1). The mixture was irradiated with light at 635 nm, 1 J cm-2, and 
the singlet oxygen generation yield was compared among the samples using a microplate reader 
(excitation wavelength of 504 nm; emission wavelength of 525 nm). For hydroxyl radical, the 
probe 3'-(p-hydroxyphenyl) fluorescein was added to the nanorods suspensions in a final 
concentration of 5 µmol L-1 (with and without photosensitizer in a concentration of 4 µmol L-
1). The mixture was irradiated with light at 635 nm, 1 J cm-2, and the hydroxyl radical 
generation yield was compared among the samples using a microplate reader (excitation 
wavelength of 490 nm; emission wavelength of 515 nm). 
 
2.5. In vitro photodynamic and hyperthermic procedure 
 The efficacy of the gold nanorods-phthalocyanine complexes regarding cancer ablation 
was assessed in vitro using melanotic melanoma cells (B16F10 cell line) and non-melanotic 
melanoma cells (B16G4F cell line). The same wavelength was used for PDT and hyperthermia 
induction, and in the case of gold nanorods with attached phthalocyanines, these two therapeutic 
interventions happened simultaneously and with the same parameters.  
 The cells were cultured in 96-well plates, 9000 cells per well, containing DMEM media 
supplemented with 10% fetal bovine serum (FBS). After 24 hours of incubation, the medium 
was replaced by DMEM without FBS and containing: 1- ZnTcPc-coated nanorods; 2- ZnTcPc-
G-coated nanorods; 3- nanorods without photosensitizer; 4- ZnTcPc solution; 5- ZnTcPc-G 
solution; 6- Phosphate Buffered Saline (PBS). 5 hours later, the wells were washed with fresh 
medium and irradiated with light at 635 nm, 5 J cm-2. The temperature of the medium was 
monitored with a laser thermometer during the whole procedure. After the irradiation, the cells 
were incubated again for 24 hours with the supplemented medium, and then the cell viability 
was assessed using Presto Blue dye. The data were compared among the groups by a variance 
analysis. 
 
 
 
3. RESULTS 
 
3.1. Nanorods coating with photosensitizers 
 The coating of the nanorods with phthalocyanines was more successful for ZnTcPc 
(80% of the photosensitizer remained attached) compared to ZnTcPc-G (20% of the 
photosensitizer remained attached). This might have occurred because of the negatively-charged 
carboxyl groups from ZnTcPc, which tend to form ionic complexes with CTAB easier than the 
methylglucamine radicals. Figures 1 and 2 show the absorption spectrum of the complexes, and 
the absorption values in 680 nm (the peak of the phthalocyanines) were the following: 0.516 for 
the supernatant obtained after centrifugation of ZnTcPc-G-coated nanorods, 0.650 for ZnTcPc-
G solution, 0.124 for the supernatant obtained after centrifugation of ZnTcPc-coated nanorods, 
and 0.650 for ZnTcPc solution. 
 The morphology of the nanorods did not change significantly after the addition of the 
photosensitizers, but we could observe lower aggregation in the presence of photosensitizers. 
Using ImageJ software, we could assess the dimensions of the nanoparticles. The mean length 
of gold nanorods was 51±9.4 nm, and the mean diameter was 6±0.8 nm. For ZnTcPc-coated 
nanorods, the mean length was 57.5±6.0 nm and the diameter was 5±1.5 nm. Finally, for 
ZnTcPc-G-coated nanorods, the mean length was 56.4±10.6 nm, and the mean diameter was 
6±1.6 nm. Figure 3 shows the TEM images obtained. 
300 400 500 600 700
0,0
0,2
0,4
0,6
0,8
1,0
1,2
1,4
1,6
1,8
2,0
No
rm
al
iz
ed
 a
bs
or
ba
nc
e 
(a
.u
.)
Wavelength (nm)
 
Figure 1. Absorption spectra of gold nanorods, covered or not with ZnTcPc-G, before 
and after centrifugation. (- -) ZnTcPc-G solution; (…) non-centrifuged ZnTcPc-G-
coated nanorods; (-.-) centrifuged ZnTcPc-G-coated nanorods; (-..-) supernatant of 
ZnTcPc-G-coated nanorods; (---) Nanorods. 
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Figure 2. Absorption spectra of gold nanorods covered or not with ZnTcPc, before and 
after centrifugation. (- -) ZnTcPc solution; (…) non-centrifuged ZnTcPc-coated 
nanorods; (-.-) centrifuged ZnTcPc-coated nanorods; (-..-) supernatant of ZnTcPc-
coated nanorods; (---) Nanorods. 
 
  
 
Figure 3. TEM images of the nanorods. (A) Gold nanorods, 18,000X; (B) Gold 
nanorods, 46,000X; (C) ZnTcPc-G-coated nanorods, 18,000X; (D) ZnTcPc-G-coated 
nanorods, 46,000X; (E) ZnTcPc-coated nanorods, 18,000X; (F) ZnTcPc-coated 
nanorods, 46,000X. 
 
 
3.2. Singlet oxygen and hydroxyl radical generation 
 The probe for singlet oxygen revealed that the phthalocyanines alone generated low 
amounts of this reactive species in aqueous solution, and the results were similar for both 
photosensitizers. However, after being attached on the nanorods surface, the singlet oxygen 
yield increased 3-fold, therefore, the type II photodynamic mechanism is augmented. As 
expected, the nanorods alone did not generate singlet oxygen. Figure 4 shows the results for 
singlet oxygen. 
 The results for hydroxyl radicals generation revealed a decrease in HPF fluorescence for 
ZnTcPc, but an increase in HPF fluorescence for ZnTcPc-G. Briefly, ZnTcPc attached to 
nanorods generated 30% less hydroxyl radicals than the free photosensitizer, and ZnTcPc-G 
attached to nanorods generated 34% more hydroxyl radicals than the free photosensitizer. As 
expected, the nanorods alone did not produce hydroxyl radicals with the irradiation. The results 
for hydroxyl radicals are shown in figure 5. 
 
 
 
 
Figure 4. Results for singlet oxygen generation in solution, corresponding to the 
fluorescence of SOSG probe after irradiation with light in 660 nm (light dose: 1 J cm-2). 
G refers to ZnTcPc-G, Z refers to ZnTcPc, and NR refers to the gold nanorods. The 
excitation and emission wavelengths of the probe were 504 nm and 525 nm, 
respectively. 
 
 
  
Figure 5. Results for hydroxyl radical generation in solution corresponding to the 
fluorescence of HPF probe after irradiation with light in 660 nm (light dose: 1 J cm-2). G 
refers to ZnTcPc-G, Z refers to ZnTcPc, and NR refers to the gold nanorods. The 
excitation and emission wavelengths of the probe were 490 nm and 515 nm, 
respectively. 
 
 
3.3. Photodynamic therapy in vitro on melanoma cells 
 The results in vitro were similar for both photosensitizers. There was a slight toxicity in 
the dark caused by the gold nanorods (with or without attached photosensitizers), probably 
because there was still some traces of free CTAB in the samples. The nanorods per se were able 
to eliminate 43% of non-melanotic melanoma cells (B16G4F) and 49% of melanotic melanoma 
cells (B16F10) due to hyperthermia after irradiating 20 J cm-2 of light in 635 nm (there was a 
6ºC increase in the temperature). When the photosensitizers were attached to the nanorods, the 
cell damage increased significantly: 91% of B16G4F elimination, and 95% of B16F10 
elimination. It is interesting to notice that the melanotic cells are more susceptible to the 
combined hyperthermic and photodynamic therapies, although melanin absorbs red light and 
could compete with the photosensitizers. One possible explanation relies on the effect of 
hyperthermia on cell membranes. It is possible that hyperthermia is able to disrupt the 
membrane of some organelles, including melanosomes, liberating cytotoxic melanin precursors 
and synthesis products to the cytosol. These compounds, such as some quinones, semiquinones, 
peroxide and superoxide, can lead the cells to necrosis and apoptosis, as observed in the cultures 
from our study (data not shown) (16). The figures 6 and 7 show the results in vitro. 
 
 Figure 6. Fluorescence of Presto Blue as an indicative of cell viability after light 
irradiation (635 nm, 20 J cm-2). G refers to ZnTcPc-G, and Z refers to ZnTcPc. NR 
refers to the gold nanorods without photosensitizer attachment. 
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Figure 7. Fluorescence of Presto Blue as an indicative of cell viability after light 
irradiation (635 nm, 20 J cm-2). G refers to ZnTcPc-G, and Z refers to ZnTcPc. NR 
refers to the gold nanorods without photosensitizer attachment. 
 
 
 
4. DISCUSSION 
 
 
 The first choices for the treatment of cancer are usually chemotherapy, radiotherapy and 
surgical removal of solid tumors, but it is known that those interventions are very invasive and 
the prognosis is often poor. The high regrowth rates observed after classic cancer treatments, as 
well as the organic impairment caused by them, boosted the search for safer and more efficient 
techniques for tumor ablation. The urge for novel treatments is even higher for fast-growing and 
highly metastatic cancers, such as melanoma. In this matter, light-based therapeutic 
interventions offer a great potential to be applied for main and ajuvant cancer therapies, i.e. 
photothermic and photodynamic therapies (2). 
 Many studies demonstrate that hyperthermia immediately after PDT enhances the 
efficacy of both treatments. This happens probably because of an inhibition of the cellular repair 
system caused by PDT, or because hyperthermia also inhibits the repair response against PDT. 
There is a synergistic effect as well, since PDT induces mitochondrial damage while 
hyperthermia induces damages in other organelles, such as nucleus and plasma membrane 
which are not oxidized by the singlet oxygen produced in the mitochondria (17,18). In this 
study, we investigated if this synergism remains when both therapies are performed 
simultaneously. 
 Initially, the synthesis of nanorods was successful, and we could obtain nanorods with 
homogeneous dimensions after the addition of silver in the synthesis medium. The nanorods 
presented around 55 nm length and 6 nm diameter. 
 Regarding their photodynamic activity after the attachment of phthalocyanines, the 
singlet oxygen generation increased three times for both photosensitizers, suggesting that a 
modification on the photodynamic mechanism might have occurred. The results with HPF probe 
reinforced the idea that the photosensitizers undergo a modification in their photodynamic 
mechanism. Apparently, they can suffer a transition from a type I (hydroxyl, superoxide and 
peroxynitrite radicals generation due to electron transfer from the photosensitizer to molecular 
oxygen or other biomolecules) to a type II mechanism (singlet oxygen generation due to energy 
transfer from the photosensitizer to molecular oxygen). This is more evident for ZnTcPc, which 
acts markedly with a type I mechanism, but after the attachment on the nanorods surface, this 
mechanism is decreased and the type II mechanism is augmented significantly. Both 
mechanisms are increased for ZnTcPc-G after the attachment on the nanorods. 
 Our results with hyperthermia and photodynamic therapy corroborate with the data from 
the literature, where Kuo and co-workers used the photosensitizer Indocyanine Green (ICG) 
attached to nanorods and investigated its photodynamic action. Their results show that the 
conjugated nanorods-ICG generate a higher amount of singlet oxygen than the photosensitizer 
alone, therefore being more effective. The authors hypothesize that this happens because of an 
increased intersystem crossing and a higher triplet yield of the photosensitizer, which guarantees 
a greater photostability. During the treatment in Kuo's study, the temperature rose to 46ºC, 
enough to induce a significant cell damage by hyperthermia. Since there was no apparent 
photosensitizer degradation, the conjugated nanorods-ICG have shown to be efficient and stable 
nanoparticles for in vitro and in vivo treatments (19).  
 The same mechanism of action hypothesized by Kuo et al. might be the responsible for 
the results observed in our study. Besides, there is evidence that the generation of singlet 
oxygen is increased if the photosensitizers are attached on metallic surfaces, since 
photobleaching is inhibited in this condition. Furthermore, the surface plasmons can somehow 
contribute by donating  energy or electrons to the photosensitizer, leading to a more efficient 
ROS generation (13). 
 When tested in vitro against melanotic and non-melanotic melanoma cells, the gold 
nanorods were able to eliminate over 40% of the malignant cells hyperthermically, more 
specifically 43% of B16G4F and 49% of B16F10. With 20 J cm-2, the temperature increased in 
6ºC. The results in vitro for nanorods complexed with photosensitizers were similar for ZnTcPc 
and ZnTcPc-G, and showed a significant enhancement of the tumor elimination potential. The 
complexes were able to eliminate 91% of B16G4F cells and 95% of B16F10 cells, either by 
necrosis or apoptosis. The synergism between the two therapeutic interventions can be 
explained, for instance, by the fact that the treatments alone tend to be insufficient to induce a 
thorough cell death, but when combined, the tumor damage is increased significantly. Besides, 
the thermal energy generated by the nanoparticles is able to accelerate the generation of reactive 
species, especially singlet oxygen (13). 
 Our in vitro results are in accordance with other studies involving the combination of 
hyperthermia and PDT. For instance, Hirschberg et al. investigated the combination of 5-
aminolevulinic acid-mediated PDT and hyperthermia induced by an incubator with controlled 
temperature. These two protocols were used aiming to eliminate two different cell line-derived 
spheroids: human grade IV GBM cell line and murine BT4C cells. The treatments alone were 
able to inhibit the survival in some extent, but the combination of PDT with a 25 J cm-2 fluence 
and 49ºC was able to eliminate almost completely the spheroids (20). Another study, performed 
by Trinidad and co-workers in 2014, investigated the effects of PDT (mediated by a sulphonated 
phthalocyanine, activated by light in 670 nm) combined with hyperthermia induced by gold 
nanoshells (activated by light in 810 nm) on the elimination of human FaDu squamous cells in 
vitro. Although they could not eliminate the tumor cells completely, there was a significant 
growth inhibition when the treatments were performed together, compared to the treatments 
alone (21). 
 Furthermore, Di Corato and co-workers combined magnetic hyperthermia with PDT 
mediated by Foscan for the elimination of tumor cells in vitro (Human adenocarcinoma SKOV-
3 cells) and in vivo (murine epidermoid carcinoma A431 cells grown in both flanks). The 
treatments alone were able to inhibit the tumor growth, but the combination resulted in complete 
tumor destruction in vitro as well as in vivo (22). Finally, Bolfarini et al. also investigated the 
elimination of melanoma cells with the combination of PDT and hyperthermia. Both therapies 
were applied by using magnetoliposomes loaded with a zinc phthalocyanine-based complex. 
The authors found that PDT was more effective than hyperthermia when applied separately, but 
the combination of treatments reduced the viability of B16F10 cells to about half that of PDT 
alone (23). Other authors observed similar results for the combination of both therapies, and 
their results can be found in Brodin's review study (24). 
 The fact that melanotic melanoma cells were more susceptible than amelanotic ones to 
hyperthermia and to the combined treatments suggests that melanin or the melanosomes might 
have played a role in the observed cell death. One explanation would be the disruption of the 
membrane of melanosomes caused by hyperthermia, liberating cytotoxic and genotoxic 
compounts to the cytosol, such as superoxide, peroxide, quinones and semiquinones. This 
additional cytotoxic effect would cause a greater elimination of melanotic cells (16,25). Other 
experiments must be performed in order to confirm this hypothesis. 
 
 
 
5. CONCLUSION 
 
 The attachment of the two zinc phthalocyanines on the surface of gold nanorods was 
successful, and led to a better outcome regarding melanoma elimination in vitro. The results of 
combined and simultaneous hyperthermic and photodynamic therapies was better than the 
results for the treatments alone, showing that there is, indeed, a synergistic effect when the 
photosensitizers are attached to a metallic surface, even if the treatments are not performed one 
after the other. 
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